You've got brilliant scientists. It's not just a scientific issue—it's an operational one. I'll help write CRO scopes, meticulously review assay data, flag risks early, and keep your programs Progress:  From assay tracking to data workflows, I design simple, scalable tools that surface insights early GPCR, we've built a global hub connecting over 1,300 GPCR scientists dedicated to this field.

Scientist, and a Post-doctoral Researcher position focused on GPCRs and Mitochondria. Without a solid grasp of these concepts, scientists risk misinterpreting critical data, leading to flawed This isn’t just information; it’s a strategic framework for your career. GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who need fast, curated, career-relevant intelligence to stay ahead

These sessions focus on real scientific uncertainty, not rehearsed presentations. τ/KA) or log(max/EC50)) Systematic comparison of biased agonists using modern functional assays For scientists What seems definitive during early screening can shift as assay systems, receptor expression levels, maintain interpretive discipline: Weekly advanced pharmacology lectures Monthly live AMAs for real-time scientific Forty years of pharmacological expertise — organized into a year-round framework for serious GPCR scientists

The conference had just enough attendees – enough for a great variety of scientific content and having She gave us an overview of the drugs she has participated in developing throughout her career, highlighting Sharing the round table discussion with these excellent scientists felt like a dream come true, and Maria enjoyed giving advice to those who are starting their careers in the scientific field.

delivers this week: high-impact insight into GPCR allostery, crafted for pharmacologists and biotech scientists translational scientists and GPCR specialists. This is the lens that lets scientists anticipate drug effects, decode kinetic behavior, and optimize GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who need fast, curated, career-relevant intelligence to stay ahead. 🔹 Why now?

After months of adjustments, a scientist on his team presented a data set that transformed everything They were collaborative scientific ventures, years in the making. The outcome is not just a probe; it’s a tool scientists can trust. Mini Timeline: pHSense Development Early 2020s: Rare-earth probe synthesis begins Collaborative screening access to GPCR innovators, exclusive deep-dives, and practical tools to accelerate your research or career

In this session, we explored: Strategic frameworks for early discrimination of orthosteric vs allosteric Recognizing this difference early prevents mechanistic misclassification. Integrating Chemistry and Kinetics Early Biological activity alone does not define a viable series. advancement of scaffolds likely to collapse later “Fail early” is not pessimism. years of pharmacological expertise — organized into a year-round learning framework for serious GPCR scientists

used to differentiate orthosteric from allosteric binding modes, and why establishing that distinction early Drug Discovery Summit — Boston, April 28-30 The GPCRs Targeted Drug Discovery Summit brings together scientists The data that's too early to present but too important not to discuss. Explore the library ➤ What Members Say The scientists in this community hold teaching to the same standard GPCR is the intelligence and community platform for GPCR scientists.

London, confocal imaging marathons, and a partnership built on trust and curiosity — reshaped both careers When David later shared early data — including a moment where he realized he could image an entire islet Early images showed clean, bright labeling across whole pancreatic islets. These parallelized experiments were critical for turning early ideas into a reproducible GPCR imaging Over the years, they learned from each other in ways that shifted both careers.

GPCR Modeling in Context: Then and Now When Carlsson entered the GPCR field in the early 2000s, structural His early Adenosine 2A receptor work, in collaboration with Ken Jacobson, helped establish virtual screening This dual perspective makes Carlsson a trusted partner for industry teams navigating early-stage pipelines For scientists, this is an intellectual challenge: demand more from your models.  collaboration. 🧠 Learn from the field’s top innovators. 📈 Sharpen your translational impact. 🔗 Connect with scientists

Hello GPCR Enthusiasts, Interpreting binding data isn’t optional—it’s career-defining. Career opportunities:  Postdocs in GPCR biophysics and assay development; industry scientist roles at Tailored job opportunities and career matchmaking. GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need career-relevant intelligence to stay ahead. 🔹 Why now?

The Overlooked Step in Every Discovery Program So what does that mean for discovery scientists designing In this lecture, you’ll revisit the early days of discovery: when scientists thought cellular chemistry This lecture challenges scientists to move beyond binary inhibition data and embrace a systems-level then by its enzymes.Ignoring the second gatekeeper means wasting cycles, budgets, and potentially, careers Kenakin live for an open Q&A session designed for discovery scientists.

Whether you’re early in your career or pushing the edge of MoA design, weekly lesson help you apply key models—fundamentals that fuel confidence and fluency Move beyond theory to apply selectivity, ADME, and early Read how scientific need and timing drove the leap from academia to application.  

Corner  was built to do: bring four decades of frontline discovery insight straight to discovery-phase scientists Scientists get frameworks, not guesswork. “Scientists love to control experiments. CROs have standard ways of doing them. “In industry, scientists bring targets forward. There’s no central committee handing down orders. For scientists in discovery, this means two things: Technical clarity drives survival.

It also leaves room for a truth every bench scientist knows: no reagent is ever finished being understood Why GPCR antibodies punish you early Good GPCR antibodies are notoriously hard to make, and the reasons into the same problem What gives the conversation its warmth is that neither guest set out to spend a career role few of her peers would have predicted, learning the craft, in her telling, partly by having her early

Career opportunities:  Discovery biology roles and training paths in GPCR signaling. From cAMP to femtomolar ligands, she unpacks a career at the edge of precision signaling. why. • Training Builds Innovation : Her lab model at Monash is shaping the next generation of GPCR scientists GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who need fast, curated, career-relevant intelligence to stay ahead. 🔹 Why now?

Save the dates: September 7 - 8: Join the 3rd ECI GPCR Symposium, an event by and for early career investigators Early-bird registration deadline is September 8, abstract submissions close on October 2, and final registration 2023 | GPCR Retreat November 15 - 17, 2023 | MPGPCR Conference November 20 - 23, 2023 | ASCEPT Annual Scientific Research Laboratory Specialist Associate Postdoc Research Associate Director, Regulatory Affairs Research Scientist /Senior Scientist I - Molecular Pharmacology Explore Dr.

Don't miss the 3rd ECI GPCR 2-day symposium organized by and for early career investigators (ECIs) exploring Early-bird registration and abstract submissions close on September 8, and final registration ends on , 2023) GPCR Retreat (November 2 - 4, 2023) MPGPCR Conference (November 15 -17, 2023) ASCEPT Annual Scientific Research Laboratory Specialist Associate Postdoc Research Associate Director, Regulatory Affairs Research Scientist /Senior Scientist I - Molecular Pharmacology Director, Clinical Data Management Director, Discovery Toxicology

Career opportunities:  GPCR Biology; Protein Science. Engine From Pipettes to Platforms: The Evolution of GPCR Research How GPCR Spatial Signaling Sparked a Scientific directly supports our mission to make reliable GPCR education and community infrastructure accessible to scientists and an integrated view of publications, events, insights, and opportunities designed to support your career GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

When PK is misunderstood early, Dr. Crucially, altering one does not inherently change the others—a principle often overlooked in early discovery sabotage otherwise strong ligands Effective PK optimization starts with realistic starting points Early PK integration —from scaffold design through population modeling— correlates with clinical success Scientists Each session re-centers fundamentals, sharpens judgment, and equips scientists to identify problems before

This is one of 12+ live Masterclasses planned for 2026 — all included in Premium, each one a direct scientific exchange with a leading scientist, with full replay access afterward. DiscoverX article A2A Fluorescent Competitive Binding with NanoBRET®  → Explore assay approach This Week's Scientific GPCR community is where scientists connect — across disciplines, across career stages, across the science GPCR is the intelligence and community platform for GPCR scientists.

Watch Episode 168 What does it take for a scientist to become a startup leader in biotech? For Dr. Maria Majellaro Maria’s career didn’t start with a desire to launch a company. GPCR ecosystem , GPCR online course , GPCR scientist network

Watch Episode 172 What happens when the career you planned no longer feels right? And so, that certainly shaped my interests and passions as a scientist." A career pivot is not a failure—it’s a refined strategy. Passion can lead to groundbreaking discoveries and a fulfilling career. This mindset can lead to a more fulfilling and successful career.

Watch Episode 171 Some careers are planned. Alessandro Nicoli’s wasn’t. In this blog post, we dive into his story of scientific curiosity, chance opportunities, and the unlikely The Early Days: Molecules and Mentors Alessandro began his academic life studying pharmaceutical chemistry

New Course on Pharmacologic Models The latest Terry’s Corner unlocks clinical forecasting tools few scientists errors:  Master vital models to confidently forecast outcomes, before it’s too late. ✅ Future-proof your career Find your edge:  Dodge the traps that derail real drug discovery careers.  

As scientists, we know curves don’t equal clarity. previews; positive ACCESS data for Structure Therapeutics’ oral GLP-1 agonist aleniglipron, Principal Scientist—In saturation curves, displacement assays, stoichiometry pitfalls, and kinetic traps, the lesson equips scientists A quick rating on Spotify or Apple Podcasts — and a YouTube subscribe — helps us reach more scientists GPCR Premium Membership Gives You an Edge Premium Membership is designed for scientists and teams who

This week, we focus on integration — how to align scientific disciplines before costly translational This partnership connects advanced assay and biology capabilities with the scientists and organizations Job Listings  — GPCR-specific career opportunities across academia, biotech, and pharma. Scientists living and working in developing countries can join for $25 per year — permanently set to It supports scientists refining expertise. It strengthens teams executing discovery programs.

lab results that seem contradictory This lesson isn’t just academic—it’s practical knowledge every early-stage scientist needs.

It creates conceptual scales that allow scientists to project observations from one experimental system During a recent AMA discussion, several experienced scientists raised questions about assay scaling, That predictive step is essential because discovery scientists almost always operate inside partial models For scientists entering drug discovery, the lesson is simple: most hypotheses will be wrong most compounds The scientists who strengthen their pharmacology foundations today will define tomorrow’s breakthroughs

Once the first images came in, the scientific questions multiplied: Could the probe support super-resolution The Human Reaction Behind a GPCR Imaging Milestone Scientists rarely talk about the emotional side of JB describes early experiences vividly: Seeing calcium waves flicker in cells. It gives scientists a way to feel the biology. Multi-receptor visualization in complex tissue The dream is ambitious and increasingly feasible: A catalog where scientists